Bio Blast Pharma (ORPN) Priced

Biotech developing treatments for rare and ultra-rare genetic diseases.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.13 0.00 (0.0%)
First Day Return -23.6%
Return from IPO -89.7%
 
Bio Blast Pharma IPO News more
  • .
IPO Data
IPO File Date 02/07/2014
Offer Price $11.00
Price Range $11.00 - $13.00
Offer Shares (mm) 3.2
Deal Size ($mm) 35
 
IPO Data
IPO Date 07/30/2014
Offer Price $11.00
Price Range $11.00 - $13.00
Offer Shares (mm) 3.2
Deal Size ($mm) $35
 
Underwriters
more
Business Overview
Biotech developing treatments for rare and ultra-rare genetic diseases.
Biotech developing treatments for rare and ultra-rare genetic diseases.
more
Company Data
Headquarters Tel Aviv, , Israel
Founded 2012
Employees 6
Website www.bioblast-pharma.com
 

Performance vs. IPO Index (IPOUSA)